April 2017 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2015/16 Invitation to Tender, dated 6 November 2015 and the 2016/17 Invitation to Tender, dated 3 November 2016.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand (http://www.pgnz.org.nz/pharmacode) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines (http://www.nzulm.org.nz/sponsors(external link)). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2016/17 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2020
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) | Date of subsidy change | Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
| Colecalciferol | Cap 1.25 mg (50,000 iu); 12 capsules; blister pack |
$3.85 | $2.50 | Vit.D3(Multichem) | 1 August 2017 | 1 November 2017 |
| Clarithromycin | Tab 250 mg; 14 tablets; blister pack |
$3.98 | $3.98 | Apo-Clarithromycin(Apotex) | 1 July 2017 | 1 October 2017 |
| Clarithromycin | Tab 500 mg; 14 tablets; blister pack |
$10.40 | $10.40 | Apo-Clarithromycin(Apotex) | 1 July 2017 | 1 October 2017 |
| Flucloxacillin | Inj 250 mg vial; 10 vials |
$8.80 | $9.00 | Flucloxin(Douglas) | 1 July 2017 | 1 October 2017 |
| Flucloxacillin | Inj 500 mg vial; 10 vials |
$9.20 | $9.40 | Flucloxin(Douglas) | 1 July 2017 | 1 October 2017 |
| Nifedipine | Tab long-acting 10 mg; 60 tablets; blister pack |
$17.72 | $10.63 | Adalat 10(Bayer) | 1 June 2017 | 1 September 2017 |
| Nystatin | Vaginal crm 100,000 u per 5 g with applicator(s); 75 g OP tube; | $4.71 | $4.45 | Nilstat(Aspen) | 1 June 2017 | 1 September 2017 |
Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) |
Date of listing/subsidy change for tender winning brand | Date of reference pricing of other listed brands | Sole Subsidised Supply date (and delisting of other listed brands) | Brand (Supplier) affected by reference pricing and delisting |
|---|---|---|---|---|---|---|---|---|
| Allopurinol | Tab 100 mg; 500 tablets; bottle pack |
$15.11 per 1000 tablets | $4.54 |
DP-Allopurinol |
1 November 2017 | 1 January 2018 | 1 April 2018 | Allopurinol-Apotex (Apotex) |
| Allopurinol | Tab 300 mg; 500 tablets; bottle pack |
$15.91 | $10.35 | DP-Allopurinol (Douglas) |
1 November 2017 | 1 January 2018 | 1 April 2018 | Allopurinol-Apotex (Apotex) |
| Finasteride | Tab 5 mg; 100 tablets; blister pack |
$2.08 per 30 tablets | $4.81 | Finasteride-Rex (Rex Medical) |
1 October 2017 | 1 December 2017 | 1 March 2018 | Finpro (Dr Reddys) |
| Flucloxacillin | Inj 1 g vial; 5 vial pack |
$11.60 per 10 vials | $5.22 | Flucil (Aspen) |
1 July 2017 | 1 September 2017 | 1 December 2017 | Flucloxin (Douglas) |
| Fluconazole | Cap 50 mg; 28 capsules; blister pack |
$3.49 | $2.09 | Mylan (Mylan) |
1 December 2017 | 1 February 2018 | 1 May 2018 | Ozole (Douglas) |
| Fluconazole | Cap 150 mg; 1 capsule; blister pack |
$0.71 | $0.33 | Mylan (Mylan) |
1 December 2017 | 1 February 2018 | 1 May 2018 | Ozole (Douglas) |
| Fluconazole | Cap 200 mg; 28 capsules; blister pack |
$9.69 | $5.08 | Mylan (Mylan) |
1 December 2017 | 1 February 2018 | 1 May 2018 | Ozole (Douglas) |
| Lidocaine [ligonocaine] hydrochloride | Oral (gel) soln 2%; 200 ml bottle |
$55.00 | $38.00 | Mucosoothe (Orion) |
1 August 2017 | 1 October 2017 | 1 January 2018 | Xylocaine Viscous (AstraZeneca) |
| Metoclopramide hydrochloride | Tab 10 mg; 100 tablets; blister pack |
$1.82 | $1.30 | Metoclopramide Actavis 10 (Actavis) |
1 November 2017 | 1 January 2018 | 1 April 2018 | Metamide (Mylan) |
| Nifedipine | Tab long-acting 30 mg; 30 tablets; blister pack | $3.75 | $3.14 | Adalat Oros (Bayer) |
1 October 2017 | 1 December 2017 | 1 March 2018 | Adefin XL (Mylan) |
| Nifedipine | Tab long-acting 60 mg; 30 tablets; blister pack | $5.75 | $5.67 | Adalat Oros (Bayer) |
1 October 2017 | 1 December 2017 | 1 March 2018 | Adefin XL (Mylan) |
| Nystatin | Oral liq 100,000 u per ml; 24 ml bottle; OP |
$2.55 | $1.95 | Nilstat (Aspen) |
1 August 2017 | 1 October 2017 | 1 January 2018 | m-Nystatin (Multichem) |
| Simvastatin | Tab 10 mg; 90 tablets; blister pack | $0.95 | $0.95 | Simvastatin Mylan (Mylan) |
1 November 2017 | 1 January 2018 | 1 April 2018 | Arrow-Simva 10 mg (Actavis) |
| Simvastatin | Tab 20 mg; 90 tablets; blister pack | $1.61 | $1.52 | Simvastatin Mylan (Mylan) |
1 November 2017 | 1 January 2018 | 1 April 2018 | Arrow-Simva 20 mg (Actavis) |
| Simvastatin | Tab 40 mg; 90 tablets; blister pack | $2.83 | $2.63 | Simvastatin Mylan (Mylan) |
1 November 2017 | 1 January 2018 | 1 April 2018 | Arrow-Simva 40 mg (Actavis) |
| Simvastatin | Tab 80 mg; 90 tablets; blister pack | $7.91 | $6.00 | Simvastatin Mylan (Mylan) |
1 November 2017 | 1 January 2018 | 1 April 2018 | Arrow-Simva 80 mg (Actavis) |
| Terbinafine | Tab 250 mg; 14 tablets; blister pack | $1.50 | $1.33 | Rex Medical (Rex Medical) |
1 November 2017 | 1 January 2018 | 1 April 2018 | Dr Reddys Terbinafine (Dr Reddys) |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Current price | New price | Hospital Supply Brand (Supplier) |
DVLimit | Listing date | Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
| Colecalciferol | Cap 1.25 mg (50,000 iu); 12 capsules; blister pack |
$3.85 | $2.50 | Vit.D3 (Multichem) |
1% | 1 August 2017 | 1 October 2017 |
| Clarithromycin | Tab 250 mg; 14 tablets; blister pack |
$3.98 | $3.98 | Apo-Clarithromycin (Apotex) |
1% | 1 July 2017 | 1 September 2017 |
| Clarithromycin | Tab 500 mg; 14 tablets; blister pack |
$10.40 | $10.40 | Apo-Clarithromycin (Apotex) |
1% | 1 July 2017 | 1 September 2017 |
| Clarithromycin | Inj 500 mg; 1 vial |
$20.40 | $12.04 | Martindale (Max Health) |
1% | 1 July 2017 | 1 September 2017 |
| Emulsifying ointment | Oint BP; 100 g pot |
$1.84 | $1.84 | Jaychem (Jaychem) |
1% | 1 August 2017 | 1 October 2017 |
| Ephedrine | Inj 30 mg per ml, 1 ml ampoule; 10 ampoules |
$51.48 | $36.04 | Max Health (Max Health) |
1% | 1 July 2017 | 1 September 2017 |
| Flucloxacillin | Inj 250 mg vial; 10 vials |
$8.80 | $9.00 | Flucloxin (Douglas) |
1% | 1 July 2017 | 1 September 2017 |
| Flucloxacillin | Inj 500 mg vial; 10 vials |
$9.20 | $9.40 | Flucloxin (Douglas) |
1% | 1 July 2017 | 1 September 2017 |
| Nifedipine | Tab long-acting 10 mg; 60 tablets; blister pack |
$17.72 | $10.63 | Adalat 10 (Bayer) |
1% | 1 June 2017 | 1 August 2017 |
| Nystatin | Vaginal crm 100,000 u per 5 g with applicator(s); 75 g tube; |
$4.71 | $4.45 | Nilstat (Aspen) |
1% | 1 June 2017 | 1 August 2017 |
Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Current price | New price | Hospital Supply Brand (Supplier) |
DVLimit | Listing date | Hospital Supply Status date | Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
| Allopurinol | Tab 100 mg; 500 tablets; bottle pack |
$15.11 per 1000 tablets | $4.54 | DP-Allopurinol (Douglas) |
1% | 1 November 2017 | 1 January 2018 | Allopurinol-Apotex (Apotex) |
| Allopurinol | Tab 300 mg; 500 tablets; bottle pack |
$15.91 | $10.35 | DP-Allopurinol (Douglas) |
1% | 1 November 2017 | 1 January 2018 | Allopurinol-Apotex (Apotex) |
| Finasteride | Tab 5 mg; 100 tablets; blister pack |
$2.08 per 30 tablets | $4.81 | Finasteride-Rex (Rex Medical) |
1% | 1 October 2017 | 1 December 2017 | Finpro (Dr Reddys) |
| Flucloxacillin | Inj 1 g vial; 5 vial pack |
$11.60 per 10 vials | $5.22 | Flucil (Aspen) |
1% | 1 July 2017 | 1 September 2017 | Flucloxin (Douglas) |
| Fluconazole | Cap 50 mg; 28 capsules; blister pack |
$3.49 | $2.09 | Mylan (Mylan) |
1% | 1 December 2017 | 1 February 2018 | Ozole (Douglas) |
| Fluconazole | Cap 150 mg; 1 capsule; blister pack |
$0.71 | $0.33 | Mylan (Mylan) |
1% | 1 December 2017 | 1 February 2018 | Ozole (Douglas) |
| Fluconazole | Cap 200 mg; 28 capsules; blister pack |
$9.69 | $5.08 | Mylan (Mylan) |
1% | 1 December 2017 | 1 February 2018 | Ozole (Douglas) |
| Lidocaine [ligonocaine] hydrochloride | Oral (gel) soln 2%; 200 ml bottle |
$55.00 | $38.00 | Mucosoothe (Orion) |
1% | 1 August 2017 | 1 October 2017 | Xylocaine Viscous (AstraZeneca) |
| Metoclopramide hydrochloride | Tab 10 mg; 100 tablets; blister pack | $1.82 | $1.30 | Metoclopramide Actavis 10 (Actavis) |
1% | 1 November 2017 | 1 January 2018 | Metamide (Mylan) |
| Nifedipine | Tab long-acting 30 mg; 30 tablets; blister pack | $3.75 | $3.14 | Adalat Oros (Bayer) |
1% | 1 October 2017 | 1 December 2017 | Adefin XL (Mylan) |
| Nifedipine | Tab long-acting 60 mg; 30 tablets; blister pack | $5.75 | $5.67 | Adalat Oros (Bayer) |
1% | 1 October 2017 | 1 December 2017 | Adefin XL (Mylan) |
| Nystatin | Oral liq 100,000 u per ml; 24 ml bottle |
$2.55 | $1.95 | Nilstat (Aspen) |
1% | 1 August 2017 | 1 October 2017 | m-Nystatin (Multichem) |
| Paracetamol | Inj 10 mg per ml, 100 ml vial; 10 vials |
$12.90 per 12 vials | $8.40 | Paracetamol Kabi (Fresenius Kabi) |
1% | 1 July 2017 | 1 September 2017 | Perfalgan (BMS) |
| Simvastatin | Tab 10 mg; 90 tablets; blister pack | $0.95 | $0.95 | Simvastatin Mylan (Mylan) |
1% | 1 November 2017 | 1 January 2018 | Arrow-Simva 10 mg (Actavis) |
| Simvastatin | Tab 20 mg; 90 tablets; blister pack | $1.61 | $1.52 | Simvastatin Mylan (Mylan) |
1% | 1 November 2017 | 1 January 2018 | Arrow-Simva 20 mg (Actavis) |
| Simvastatin | Tab 40 mg; 90 tablets; blister pack | $2.83 | $2.63 | Simvastatin Mylan (Mylan) |
1% | 1 November 2017 | 1 January 2018 | Arrow-Simva 40 mg (Actavis) |
| Simvastatin | Tab 80 mg; 90 tablets; blister pack | $7.91 | $6.00 | Simvastatin Mylan (Mylan) |
1% | 1 November 2017 | 1 January 2018 | Arrow-Simva 80 mg (Actavis) |
| Terbinafine | Tab 250 mg; 14 tablets; blister pack |
$1.50 | $1.33 | Rex Medical (Rex Medical) |
1% | 1 November 2017 | 1 January 2018 | Dr Reddys Terbinafine (Dr Reddys) |
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2016/17 Invitation to Tender, dated 3 November 2016:
2016/17 Invitation to Tender
|
Chemical Name |
Line Item |
|---|---|
|
Albendazole |
Tab 400 mg |
|
Apraclonidine |
Eye drops 0.5% |
|
Artesunate |
Inj 60 mg |
|
Cefotaxime |
Inj 500 mg |
|
Ceftazidime |
Inj 500 mg |
|
Cycloserine |
Cap 250 mg |
|
Dexamethasone |
Eye drops 0.1% |
|
Dexamethasone |
Eye oint 0.1% |
|
Dexamethasone with framycetin and gramicidin |
Ear/eye drops 500 mcg with framycetin sulphate 5 mg and gramicidin 50 mcg per ml |
|
Dexamethasone with neomycin sulphate and polymyxin B sulphate |
Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml |
|
Dexamethasone with neomycin sulphate and polymyxin B sulphate |
Eye oint 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per g |
|
Diclofenac sodium |
Inj 25 mg per ml, 3 ml |
|
Diclofenac sodium |
Suppos 12.5 mg |
|
Diclofenac sodium |
Suppos 25 mg |
|
Diclofenac sodium |
Suppos 50 mg |
|
Diclofenac sodium |
Suppos 100 mg |
|
Doxycycline hydrochloride |
Tab 50 mg |
|
Doxycycline hydrochloride |
Tab 20 - 40 mg |
|
Econazole nitrate |
Crm 1% (pack size of 30 g or less) |
|
Foscarnet sodium |
Inj 24 mg per ml, 250 ml |
|
Glyceryl trinitrate |
TDDS 50 mg, 10 mg per day |
|
Glyceryl trinitrate |
TDDS 25 mg, 5 mg per day |
|
Lamivudine |
Tab 150 mg |
|
Lamivudine |
Oral liq 10 mg per ml |
|
Lodoxamide |
Eye drops 0.1% |
|
Mebendazole |
Oral liq 100 mg per 5 ml |
|
Mebendazole |
Tab 100 mg |
|
Mercaptopurine |
Tab 10 mg |
|
Nitazoxanide |
Oral liq 100 mg per 5 ml |
|
Pancuronium bromide |
Inj 2 mg per ml, 2 ml |
|
Primaquine phosphate |
Tab 7.5 - 15 mg |
|
Pyrazinamide |
Tab 500 mg |
|
Ranitidine |
Inj 10 mg - 25 mg per ml |
|
Spiramycin |
Tab 500 mg |
|
Sulfadiazine Sodium |
Tab 500 mg |
|
Tretinoin |
Crm 0.5 mg per g |
|
Trimipramine maleate |
Cap 25 mg |
|
Trimipramine maleate |
Cap 50 mg |
|
Zinc and castor Oil |
Oint 5% or less (pack size 30 g or less) |
For products included in the 2014/15, 2015/16 and 2016/17 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.